Pfizer Wins Discovery Spat In Lipitor Off-Market Suit
Pfizer Inc. has scored a win in a fight over discovery in a case involving 11 ERISA benefit funds that claimed the drug maker improperly marketed its blockbuster cholesterol treatment Lipitor...To view the full article, register now.
Already a subscriber? Click here to view full article